Title	Publication Date	Language	Citations
Development and Evaluation of the Adherence to Refills and Medications Scale (ARMS) among Low-Literacy Patients with Chronic Disease	2009/01/01	English	246
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force	2022/01/01	English	245
Too Much Ado about Propensity Score Models? Comparing Methods of Propensity Score Matching	2006/11/01	English	241
Bayesian Meta-Analysis of Multiple Treatment Comparisons: An Introduction to Mixed Treatment Comparisons	2008/09/01	English	235
Chinese Time Trade-Off Values for EQ-5D Health States	2014/07/01	English	224
Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis	2016/07/01	English	224
Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report	2014/03/01	English	218
Hierarchical Construct Validity of the Treatment Satisfaction Questionnaire for Medication (TSQM Version II) among Outpatient Pharmacy Consumers	2005/11/01	English	217
A Systematic Review Evaluating Health-Related Quality of Life, Work Impairment, and Health-Care Costs and Utilization in Abnormal Uterine Bleeding	2007/05/01	English	217
Using Classical Test Theory, Item Response Theory, and Rasch Measurement Theory to Evaluate Patient-Reported Outcome Measures: A Comparison of Worked Examples	2015/01/01	English	216
The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management	2011/07/01	English	214
Health Economic Guidelines—Similarities, Differences and Some Implications	2001/05/01	English	210
Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force	2013/07/01	English	207
Populating an Economic Model with Health State Utility Values: Moving toward Better Practice	2010/07/01	English	206
Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II	2009/11/01	English	203
Optimal Cost-Effectiveness Decisions: The Role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI)	2008/09/01	English	198
Multiple Criteria Decision Analysis for Health Technology Assessment	2012/12/01	English	195
Multinational Trials—Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force Report	2009/06/01	English	193
Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part III	2009/11/01	English	192
Time Trade-Off Derived EQ-5D Weights for Australia	2011/09/01	English	190
Comparing the Standard EQ-5D Three-Level System with a Five-Level Version	2008/03/01	English	189
United States Valuation of EQ-5D-5L Health States Using an International Protocol	2019/08/01	English	189
Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments	2013/01/01	English	188
What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews	2017/07/01	English	186
The Mental Component of the Short-Form 12 Health Survey (SF-12) as a Measure of Depressive Disorders in the General Population: Results with Three Alternative Scoring Methods	2013/06/01	English	179
The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought	2016/12/01	English	178
Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol	2019/01/01	English	178
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review	2018/07/01	English	175
The Role of Patient-Reported Outcome Measures in Value-Based Payment Reform	2017/06/01	English	174
Using Cost-Effectiveness Analysis to Address Health Equity Concerns	2017/02/01	English	174